Fig 1: hBMMSCs transfected with hBMP4 mRNA/LNP secreted hBMP4 protein and enhanced osteogenic differentiation. (A) Schematic of experiment design. (B–D) hBMP4 protein ELISA at different time points. BMP4 secretion dose-dependently increased in the supernatant at 4 h, reaching peak expression 24 h, with the 4 µg group being significantly increased compared to CTL. Expression declined at 96 h after transfection. (E–H) Q-PCR analysis of osteogenic genes’ mRNA after 5 days of osteogenic differentiation. (I,J) Q-PCR analysis of senescence/cell cycle genes P16 and P21. Exact p values are indicated between group bars.
Fig 2: Micro-CT results of knee joint at 8 weeks after BMP4 mRNA injection. (A) Schematic experiment design and timeline. (B) 3D micro-CT images of the knee. No increase in heterotopic bone formation was observed in BMP4 mRNA at 2.5 µg and 5 µg doses compared to CTL group. Red arrows point to HO formation. The slight differences in image sizes are due to differences in total slice numbers as well as knee angle during micro-CT scanning. Scale bars = 1 mm. (C) Von Frey pain threshold. There were no statistical differences at baseline and 1 M after mRNA injection. At 2 M, both BMP4 mRNA 2.5 and 5 µg had increased pain thresholds compared to 1 M after injection, which indicated reduced pain. Exact p values are indicated between group bars. (D) ELISA results of serum HA. Exact p values are indicated between group bars.
Supplier Page from OriGene Technologies for BMP4 (NM_001202) Human Untagged Clone